{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:50:08Z","timestamp":1770486608410,"version":"3.49.0"},"reference-count":21,"publisher":"American Chemical Society (ACS)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2017,12,4]]},"DOI":"10.1021\/acs.molpharmaceut.7b00388","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T20:51:49Z","timestamp":1509137509000},"page":"4346-4352","source":"Crossref","is-referenced-by-count":15,"title":["Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen"],"prefix":"10.1021","volume":"14","author":[{"given":"Lucia","family":"Fusani","sequence":"first","affiliation":[{"name":"Drug Safety & Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1619-6250","authenticated-orcid":true,"given":"Martin","family":"Brown","sequence":"additional","affiliation":[{"name":"Discovery Sciences,\rInnovative Medicines and Early Development Biotech Unit, AstraZeneca, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongming","family":"Chen","sequence":"additional","affiliation":[{"name":"Discovery Sciences, Innovative Medicines and Early Development Biotech\rUnit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Ahlberg","sequence":"additional","affiliation":[{"name":"Drug Safety & Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-6342","authenticated-orcid":true,"given":"Tobias","family":"Noeske","sequence":"additional","affiliation":[{"name":"Drug Safety & Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, M\u00f6lndal 431 83, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623309352496"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.4.567"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/308594"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1177\/019262338501300410"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1177\/0192623309348521"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1120"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.06.014"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201200048"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90435-5"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-2993(04)70180-3"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200306"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1021\/ci500233k"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1021\/ci6004542"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.03.010"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/ci3001875"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2015.01.014"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-006-0176-z"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/S1093-3263(00)00068-1"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00994018"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010933404324"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-28"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.7b00388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T12:08:51Z","timestamp":1682165331000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.7b00388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,4]]}},"alternative-id":["10.1021\/acs.molpharmaceut.7b00388"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00388","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}